Emerging two-dimensional materials-based diagnosis of neurodegenerative diseases: Status and challenges
暂无分享,去创建一个
Jia Liu | Artem Pliss | Xueji Zhang | Ping Luan | Jun Liu | Jingwen Wu | Wentao Dong | Zhongsheng Zhang | Miriam Akioma | Yibiao Liu | Jun Liu | A. Pliss | Xueji Zhang | Yibiao Liu | Zhongsheng Zhang | Ping Luan | Jingwen Wu | Miriam Akioma | Jia Liu | Wen-sheng Dong
[1] Junjian Zhang,et al. Hypoxia Inducible Factor 1α Promotes Endogenous Adaptive Response in Rat Model of Chronic Cerebral Hypoperfusion , 2017, International journal of molecular sciences.
[2] Jungkyun Oh,et al. Ultrasensitive and Selective Organic FET-type Nonenzymatic Dopamine Sensor Based on Platinum Nanoparticles-Decorated Reduced Graphene Oxide. , 2017, ACS applied materials & interfaces.
[3] Yi Cui,et al. Energy storage: The future enabled by nanomaterials , 2019, Science.
[4] Lin Mei,et al. Surgical Tumor-Derived Personalized Photothermal Vaccine Formulation for Cancer Immunotherapy. , 2019, ACS nano.
[5] Shenshu Yang,et al. ROS and diseases: role in metabolism and energy supply , 2019, Molecular and Cellular Biochemistry.
[6] Yao-Xin Lin,et al. Peptide-Based Autophagic Gene and Cisplatin Co-delivery Systems Enable Improved Chemotherapy Resistance. , 2019, Nano letters.
[7] A. Bishayee,et al. Report on Second International Conference on Natural Products for Cancer Prevention and Therapy Held in Kayseri, Turkey, 8–11 November 2017 , 2017, Nutrients.
[8] Junle Qu,et al. Ultrathin 2D Nonlayered Tellurium Nanosheets: Facile Liquid‐Phase Exfoliation, Characterization, and Photoresponse with High Performance and Enhanced Stability , 2018 .
[9] Anne Corbett,et al. Alzheimer's disease , 2011, The Lancet.
[10] Andreas Frutiger,et al. Ultra Stable Molecular Sensors by Submicron Referencing and Why They Should Be Interrogated by Optical Diffraction—Part II. Experimental Demonstration , 2020, Sensors.
[11] R. Yuan,et al. Determination of Alzheimer biomarker DNA by using an electrode modified with in-situ precipitated molybdophosphate catalyzed by alkaline phosphatase-encapsulated DNA hydrogel and target recycling amplification , 2019, Microchimica Acta.
[12] P. Chu,et al. Black‐Phosphorus‐Incorporated Hydrogel as a Sprayable and Biodegradable Photothermal Platform for Postsurgical Treatment of Cancer , 2018, Advanced science.
[13] M. G. Savelieff,et al. Towards an understanding of amyloid-β oligomers: characterization, toxicity mechanisms, and inhibitors. , 2017, Chemical Society reviews.
[14] Pu Wang,et al. Elevating the Levels of Calcium Ions Exacerbate Alzheimer’s Disease via Inducing the Production and Aggregation of β-Amyloid Protein and Phosphorylated Tau , 2021, International journal of molecular sciences.
[15] P. Calabresi,et al. Amyloid-β: a potential link between epilepsy and cognitive decline , 2021, Nature Reviews Neurology.
[16] M. Geschwind,et al. Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases. , 2018, Cold Spring Harbor perspectives in biology.
[17] K. Blennow,et al. Biomarkers for Alzheimer's disease: current status and prospects for the future , 2018, Journal of internal medicine.
[18] Y. Chen,et al. Neurotensin‐Conjugated Reduced Graphene Oxide with Multi‐Stage Near‐Infrared‐Triggered Synergic Targeted Neuron Gene Transfection In Vitro and In Vivo for Neurodegenerative Disease Therapy , 2016, Advanced healthcare materials.
[19] O. Muskens,et al. Graphene Oxide-Upconversion Nanoparticle Based Optical Sensors for Targeted Detection of mRNA Biomarkers Present in Alzheimer's Disease and Prostate Cancer. , 2017, ACS sensors.
[20] Pandiyarasan Veluswamy,et al. Direct electrochemical reduction of hematite decorated graphene oxide (α-Fe2O3@erGO) nanocomposite for selective detection of Parkinson's disease biomarker. , 2018, Biosensors & bioelectronics.
[21] Chia-Liang Sun,et al. Synthesis of short graphene oxide nanoribbons for improved biomarker detection of Parkinson's disease. , 2015, Biosensors & bioelectronics.
[22] D. Eisenberg,et al. Propagation of Tau Aggregates and Neurodegeneration. , 2017, Annual review of neuroscience.
[23] M. Zaretskaia,et al. Mini-review: Amyloid degradation toxicity hypothesis of Alzheimer’s disease , 2021, Neuroscience Letters.
[24] M. Tsimidou,et al. Special Issue “Saffron (Crocus sativus, L.): Omics and Other Techniques in Authenticity, Quality, and Bioactivity Studies” , 2016, Molecules.
[25] Münteha Nur Sonuç Karaboğa,et al. Analysis of Tau-441 protein in clinical samples using rGO/AuNP nanocomposite-supported disposable impedimetric neuro-biosensing platform: Towards Alzheimer's disease detection. , 2020, Talanta.
[26] S. S. Sinha,et al. Hybrid Graphene Oxide Based Plasmonic-Magnetic Multifunctional Nanoplatform for Selective Separation and Label-Free Identification of Alzheimer's Disease Biomarkers. , 2015, ACS applied materials & interfaces.
[27] R. Kukreti,et al. Oxidative Stress: A Key Modulator in Neurodegenerative Diseases , 2019, Molecules.
[28] S. Strack,et al. Mitochondrial dynamics in neuronal injury, development and plasticity , 2017, Journal of Cell Science.
[29] J. Andersen,et al. Mechanisms of SOD1 regulation by post-translational modifications , 2019, Redox biology.
[30] Laurence Eaves,et al. High electron mobility, quantum Hall effect and anomalous optical response in atomically thin InSe. , 2017, Nature nanotechnology.
[31] A. Nouvenne,et al. Uric Acid and Cognitive Function in Older Individuals , 2018, Nutrients.
[32] Tae Hoon Lee,et al. ZnO nanowire arrays on 3D hierachical graphene foam: biomarker detection of Parkinson's disease. , 2014, ACS nano.
[33] Han Zhang,et al. Two-Dimensional Black Phosphorus Nanomaterials: Emerging Advances in Electrochemical Energy Storage Science , 2020, Nano-micro letters.
[34] P. Shaw,et al. The role of mitochondria in amyotrophic lateral sclerosis , 2017, Neuroscience Letters.
[35] A. Musto,et al. The role of inflammation in the development of epilepsy , 2018, Journal of Neuroinflammation.
[36] P. Carloni,et al. Structural Determinants of the Prion Protein N-Terminus and Its Adducts with Copper Ions , 2018, International journal of molecular sciences.
[37] Y. Joseph,et al. Structure–Function Relationships of Nanocarbon/Polymer Composites for Chemiresistive Sensing: A Review , 2021, Sensors.
[38] F. Zhang,et al. Revealing of the ultrafast third-order nonlinear optical response and enabled photonic application in two-dimensional tin sulfide , 2019, Photonics Research.
[39] M. Walker. Pathophysiology of status epilepticus , 2016, Neuroscience Letters.
[40] D. Hulisz. Amyotrophic lateral sclerosis: disease state overview. , 2018, The American journal of managed care.
[41] Yao-Xin Lin,et al. Polydopamine‐Modified Black Phosphorous Nanocapsule with Enhanced Stability and Photothermal Performance for Tumor Multimodal Treatments , 2018, Advanced science.
[42] C. Jack,et al. Alzheimer's disease: The next frontier—Special Report 2017 , 2017, Alzheimer's & Dementia.
[43] Ramón Cacabelos,et al. Parkinson’s Disease: From Pathogenesis to Pharmacogenomics , 2017, International journal of molecular sciences.
[44] M. Filip,et al. Oxidative Stress in Neurodegenerative Diseases , 2015, Molecular Neurobiology.
[45] Dianyuan Fan,et al. 2D Nonlayered Selenium Nanosheets: Facile Synthesis, Photoluminescence, and Ultrafast Photonics , 2017 .
[46] M. Hayes. Parkinson's Disease and Parkinsonism. , 2019, The American journal of medicine.
[47] K. Yung,et al. Roles of Glutamate Receptors in Parkinson’s Disease , 2019, International journal of molecular sciences.
[48] P. Chu,et al. Surface Coordination of Black Phosphorus for Robust Air and Water Stability. , 2016, Angewandte Chemie.
[49] E. Wild,et al. Huntington's Disease Clinical Trials Corner: March 2020. , 2020, Journal of Huntington's disease.
[50] Huaiyu Wang,et al. Few-Layered Black Phosphorus: From Fabrication and Customization to Biomedical Applications. , 2018, Small.
[51] Xionghui Wei,et al. Carbon-Based Nanocomposites as Fenton-Like Catalysts in Wastewater Treatment Applications: A Review , 2021, Materials.
[52] Weiran Ye,et al. A sensitive detection assay based on signal amplification technology for Alzheimer's disease's early biomarker in exosome. , 2018, Analytica chimica acta.
[53] Hyunjoon Kong,et al. Reactive oxygen species-responsive drug delivery systems for the treatment of neurodegenerative diseases. , 2019, Biomaterials.
[54] K. Blennow,et al. Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders. , 2020, JAMA.
[55] D. Panagiotakos,et al. Evaluation of dietary and lifestyle changes as modifiers of S100β levels in Alzheimer’s disease , 2017, Nutritional neuroscience.
[56] P. Chu,et al. Near-infrared light control of bone regeneration with biodegradable photothermal osteoimplant. , 2019, Biomaterials.
[57] Yinyi Sun,et al. Autophagy and inflammation in ischemic stroke , 2020, Neural regeneration research.
[58] Zhen Yuan,et al. The effect of V‐ATPase function defects in pathogenesis of Alzheimer's disease , 2018, CNS neuroscience & therapeutics.
[59] A. Atri. The Alzheimer's Disease Clinical Spectrum: Diagnosis and Management. , 2019, The Medical clinics of North America.
[60] Tae Geun Kim,et al. Enhancing surface functionality of reduced graphene oxide biosensors by oxygen plasma treatment for Alzheimer's disease diagnosis. , 2017, Biosensors & bioelectronics.
[61] Wei Cheng,et al. NIR-Light-Activated Combination Therapy with a Precise Ratio of Photosensitizer and Prodrug Using a Host-Guest Strategy. , 2019, Angewandte Chemie.
[62] Shen-ming Chen,et al. Ultrasound-assisted synthesis of α-MnS (alabandite) nanoparticles decorated reduced graphene oxide hybrids: Enhanced electrocatalyst for electrochemical detection of Parkinson's disease biomarker. , 2019, Ultrasonics sonochemistry.
[63] Sonja W. Scholz,et al. Challenges in the diagnosis of Parkinson's disease , 2021, The Lancet Neurology.
[64] Michelle Grayson. Parkinson's disease , 2016, Nature.
[65] Josep Ferré-Borrull,et al. A photoelectrochemical sandwich immunoassay for protein S100β, a biomarker for Alzheimer’s disease, using an ITO electrode modified with a reduced graphene oxide-gold conjugate and CdS-labeled secondary antibody , 2019, Microchimica Acta.
[66] O. Forlenza,et al. Mitochondrial dysfunction in Alzheimer's disease: Therapeutic implications of lithium , 2021, Neuroscience Letters.
[67] A. Pliss,et al. Synergic treatment of Alzheimer’s disease with brain targeted nanoparticles incorporating NgR-siRNA and brain derived neurotrophic factor , 2020 .
[68] K. Blennow,et al. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts , 2020, The Lancet Neurology.
[69] Saptarshi Das,et al. Mimicking Neurotransmitter Release in Chemical Synapses via Hysteresis Engineering in MoS2 Transistors. , 2017, ACS nano.
[70] Josemir W. Sander,et al. Epilepsy is a neurological and a systemic disorder , 2018, Epilepsy & Behavior.
[71] M. Sabbagh,et al. Diagnosis of Early Alzheimer’s Disease: Clinical Practice in 2021 , 2021, The Journal of Prevention of Alzheimer's Disease.
[72] J. Hardy,et al. The amyloid hypothesis of Alzheimer's disease at 25 years , 2016, EMBO molecular medicine.
[73] A. Mamun,et al. Toxic tau: structural origins of tau aggregation in Alzheimer's disease , 2020, Neural regeneration research.
[74] M. Rahaie,et al. A nanobiosensor based on graphene oxide and DNA binding dye for multi-microRNAs detection , 2019, Bioscience reports.
[75] Y. Liu,et al. Recent advances in black phosphorus-based electrochemical sensors: A review. , 2021, Analytica chimica acta.
[76] L. Alvarez,et al. Lignans from Bursera fagaroides Affect In Vivo Cell Behavior by Disturbing the Tubulin Cytoskeleton in Zebrafish Embryos , 2018, Molecules.
[77] D. Fan,et al. Few‐Layer Tin Sulfide: A Promising Black‐Phosphorus‐Analogue 2D Material with Exceptionally Large Nonlinear Optical Response, High Stability, and Applications in All‐Optical Switching and Wavelength Conversion , 2018 .
[78] T. Davis,et al. Regulation of blood–brain barrier integrity by microglia in health and disease: A therapeutic opportunity , 2020, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[79] C. Frost,et al. A Metabolic Study of Huntington’s Disease , 2016, PloS one.
[80] E. Pop,et al. Ultrahigh thermal isolation across heterogeneously layered two-dimensional materials , 2019, Science Advances.
[81] E. Ruppin,et al. Mitochondrial Regulation of the Hippocampal Firing Rate Set Point and Seizure Susceptibility , 2019, Neuron.
[82] K. Ghaedi,et al. Huntington’s Disease and Mitochondria , 2017, Neurotoxicity Research.
[83] Wendy Noble,et al. Roles of tau protein in health and disease , 2017, Acta Neuropathologica.
[84] Paul M. Thompson,et al. Age, APOE and sex: Triad of risk of Alzheimer’s disease , 2016, The Journal of Steroid Biochemistry and Molecular Biology.
[85] X. Qu,et al. Label-free ratiometric electrochemical detection of the mutated apolipoprotein E gene associated with Alzheimer's disease. , 2016, Chemical communications.
[86] P. Abete,et al. Oxidative stress, aging, and diseases , 2018, Clinical interventions in aging.
[87] M. Tremblay,et al. Chronic stress as a risk factor for Alzheimer's disease: Roles of microglia-mediated synaptic remodeling, inflammation, and oxidative stress , 2018, Neurobiology of Stress.
[88] G. Koelsch. BACE1 Function and Inhibition: Implications of Intervention in the Amyloid Pathway of Alzheimer’s Disease Pathology , 2017, Molecules.
[89] H. Tian,et al. Fluorogenic resveratrol-confined graphene oxide for economic and rapid detection of Alzheimer's disease. , 2014, ACS applied materials & interfaces.